Cronos Group Inc. (CRON) vs Castle Biosciences, Inc. (CSTL)

A side-by-side comparison of Cronos Group Inc. and Castle Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRON vs CSTL

growth of $100 · dividends reinvested · last 7y
CRON -78.9% (-19.9%/yr)CSTL +71.3% (+8.0%/yr)CSTL compounded faster over this window
Log scale — wide-divergence pair
101001kStart $100202120232025$21$171
CRON CSTL

CRON vs CSTL: by the numbers

  • •CRON is the larger company ($1.22B vs $1.12B market cap).
  • •CRON is profitable (30.98% net margin) while CSTL runs a net loss (-5.43%).
  • •CSTL grew revenue faster over the past five years (35.55% vs 31.80% CAGR).

Metrics side by side

Valuation

MetricCRONCSTL
P/E ratio18.00N/A
P/S ratio5.413.14
P/B ratio1.142.39
EV / EBITDA27.74N/A
FCF yield4.08%N/A

Profitability

MetricCRONCSTL
Gross margin36.16%77.26%
Operating margin-11.96%-8.99%
Net margin30.98%-5.43%
ROE6.53%-4.13%
ROIC1.12%-6.33%

Growth (annualized)

MetricCRONCSTL
Revenue CAGR (5Y)31.80%35.55%
Total return CAGR (5Y)-9.92%-10.28%

Frequently asked

Which has grown faster, CRON or CSTL?
Over the past five years, CSTL grew revenue faster — CRON at a 31.80% CAGR versus CSTL at 35.55%.
Is CRON or CSTL more profitable?
CRON runs the higher net margin — CRON at 30.98% versus CSTL at -5.43%.
How have CRON and CSTL total returns compared?
Over the past 5 years, CRON delivered -9.92% and CSTL delivered -10.28% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.